AGAP2 and breast cancer: An opposing conclusion was made regarding the therapeutic use of MSC-derived exosomal ncRNA and cancer, whereby expression of various lncRNAs (AGAP2-AS1 and HCP5) promoted stemness and drug resistance in breast cancer and gastric cancer, respectively.